Global and United States Oxytocic Pharmaceuticals Market Insights, Forecast to 2027

Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.

Market Analysis and Insights: Global and United States Oxytocic Pharmaceuticals Market
This report focuses on global and United States Oxytocic Pharmaceuticals market.
In 2020, the global Oxytocic Pharmaceuticals market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Oxytocic Pharmaceuticals market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Oxytocic Pharmaceuticals Scope and Market Size
Oxytocic Pharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oxytocic Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Oxytocic Pharmaceuticals market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Natural Oxytocin
Synthetic Oxytocin Derivative

Segment by Application
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva